Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Soluble ST2 links inflammation to outcome after subarachnoid hemorrhage

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. POPDC3 Gene Variants Associate with a New Form of Limb Girdle Muscular Dystrophy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Autism and developmental disability caused by KCNQ3 gain-of-function variants

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Residual Descending Motor Pathways Influence Spasticity after Spinal Cord Injury

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Continuous EEG Monitoring in a Consecutive Patient Cohort with Sepsis and Delirium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Transcerebral exchange kinetics of large neutral amino acids during acute inspiratory hypoxia in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage: Functional outcome and long-term mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. High-dose naloxone, an experimental tool uncovering latent sensitisation: pharmacokinetics in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Aneurismal subaraknoidalblødning

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Matthew B Bevers
  • Zoe Wolcott
  • Søren Bache
  • Christina Hansen
  • Cristina Sastre
  • Ravi Mylvaganam
  • Matthew J Koch
  • Aman B Patel
  • Kirsten Møller
  • W Taylor Kimberly
Vis graf over relationer

OBJECTIVE: To investigate whether soluble growth stimulation expressed gene 2 (sST2), a prognostic marker in cardiovascular and inflammatory disorders, is associated with neurological injury after aneurysmal subarachnoid hemorrhage (SAH).

METHODS: We studied SAH patients from 2 independent cohorts. Outcome assessments included functional status at 90 days using the modified Rankin Scale (mRS), mortality, and delayed cerebral ischemia (DCI). The relationships between sST2 plasma level and outcome measures were assessed in both cross-sectional and longitudinal analysis. Primary blood mononuclear cells from SAH patients and elective aneurysm controls were analyzed by multiparameter flow cytometry.

RESULTS: In the discovery cohort, sST2 predicted 90-day mRS 3-6 (C index = 0.724, p < 0.001) and mortality in Kaplan-Meier analysis (p < 0.001). The association with functional status was independent of age, sex, World Federation of Neurosurgical Societies score, modified Fisher score, treatment modality, and cardiac comorbidities (adjusted odds ratio = 2.28, 95% confidence interval = 1.04-5.00, p = 0.039). Higher sST2 concentration was observed in those patients with DCI (90.8 vs 53.7ng/ml, p = 0.003). These associations were confirmed in a replication cohort. In patients with high sST2, flow cytometry identified decreased expression of CD14 (4.27 × 105 ± 2,950 arbitrary unit (AU) vs 5.64 × 105 ± 1,290 AU, p < 0.001), and increased expression of CD16 (39,960 ± 272 AU vs 34,869 ± 183 AU, p < 0.001).

INTERPRETATION: Plasma sST2 predicts DCI, functional outcome, and mortality after SAH, independent of clinical and radiographic markers. Elevated sST2 is also associated with changes in CD14+ CD16+ monocytes. ANN NEUROL 2019;86:384-394.

OriginalsprogEngelsk
TidsskriftAnnals of Neurology
Vol/bind86
Udgave nummer3
Sider (fra-til)384-394
Antal sider11
ISSN0364-5134
DOI
StatusUdgivet - sep. 2019

Bibliografisk note

© 2019 American Neurological Association.

ID: 58928179